Hyperthermic intraperitoneal chemotherapy (HIPEC) is a locoregional therapy that may be
combined with cytoreductive surgery (CRS) to treat patients with colorectal cancer and …

Simple Summary Gastric cancer is usually diagnosed at late stages and is associated with
poor five-year survival rates. Metastasis to the peritoneal cavity is common and leads to …

The peritoneum is a common site of metastases for gastrointestinal tumors that predicts a
poor outcome. In addition to decreased survival, peritoneal metastases (PMs) can …

Background Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
(CRS/HIPEC) are complex operations for the treatment of peritoneal metastases. Enhanced …

Background Two-stage expander implant breast reconstruction is commonly performed after
mastectomy. Salvage and long-term outcomes after development of complications have not …

Background Thrombocytosis following splenectomy is a common occurrence. Whether this
thrombocytosis leads to a higher risk for venous thromboembolism (VTE) remains unclear …

Results In total, 85 caregiver surveys were completed for 82 patients. Median patient age
was 58 years, the majority of cancers were primary gastrointestinal (65%) or gynecologic …

Objective: Recent studies reveal a high occurrence of overdiagnosis of heparin-induced
thrombocytopenia in surgical patients with critical illness. The optimal criteria for diagnosis of …

Background Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-
HIPEC) for patients with peritoneal carcinomatosis is promising but has potential for …

Background Patients hospitalized with COVID-19 are at risk of developing hypoxic
respiratory failure and often require prolonged mechanical ventilation. Indication and timing …